Skip to main content
CING
NASDAQ Life Sciences

Cingulate Inc. Expands At-The-Market Offering by $8.84 Million, Signaling Significant Dilution

Analisis de IA por Wiseek
Sentimiento info
Negativo
Importancia info
8
Precio
$5.44
Cap. de mercado
$40.508M
Min. 52 sem.
$3.2
Max. 52 sem.
$6.01
Market data snapshot near publication time

summarizeResumen

Cingulate Inc. has significantly expanded its At-The-Market (ATM) offering program, increasing the maximum aggregate offering price by $8.4 million to a total of $31.9 million. Concurrently, the company filed a prospectus supplement for an additional $8.84 million under this expanded program. This substantial capital raise, representing a significant portion of the company's market capitalization, indicates a strong need for funding and will result in considerable dilution for existing shareholders. Investors should monitor the pace and pricing of these sales as they occur, as continuous share issuance can create an overhang on the stock price.


check_boxEventos clave

  • ATM Program Expansion

    Cingulate Inc. increased the maximum aggregate offering price of its At-The-Market (ATM) offering agreement from $23,536,658 to $31,936,658.

  • New Offering Tranche

    The company filed a prospectus supplement for an additional $8,840,000 of common stock under the expanded ATM program.

  • Significant Dilution Potential

    This capital raise represents a substantial portion of the company's current market capitalization, indicating significant potential dilution for existing shareholders.


auto_awesomeAnalisis

Cingulate Inc. has significantly expanded its At-The-Market (ATM) offering program, increasing the maximum aggregate offering price by $8.4 million to a total of $31.9 million. Concurrently, the company filed a prospectus supplement for an additional $8.84 million under this expanded program. This substantial capital raise, representing a significant portion of the company's market capitalization, indicates a strong need for funding and will result in considerable dilution for existing shareholders. Investors should monitor the pace and pricing of these sales as they occur, as continuous share issuance can create an overhang on the stock price.

En el momento de esta presentación, CING cotizaba a 5,44 $ en NASDAQ dentro del sector Life Sciences, con una capitalización de mercado de aproximadamente 40,5 M$. El rango de cotización de 52 semanas fue de 3,20 $ a 6,01 $. Este documento fue evaluado con un sentimiento de mercado negativo y una puntuación de importancia de 8 sobre 10.

descriptionVer presentacion principal de la SEC

show_chartGrafico de precios

Compartir este articulo

Copied!

feed CING - Ultimos analisis

CING
Apr 28, 2026, 4:24 PM EDT
Filing Type: 424B3
Importance Score:
8
CING
Apr 14, 2026, 5:26 PM EDT
Filing Type: S-3
Importance Score:
8
CING
Mar 27, 2026, 4:01 PM EDT
Filing Type: 424B3
Importance Score:
8
CING
Mar 26, 2026, 4:24 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
CING
Mar 24, 2026, 5:14 PM EDT
Filing Type: 8-K
Importance Score:
9
CING
Mar 24, 2026, 5:13 PM EDT
Filing Type: 424B3
Importance Score:
9
CING
Mar 19, 2026, 6:00 PM EDT
Filing Type: S-3
Importance Score:
8
CING
Mar 18, 2026, 4:30 PM EDT
Filing Type: DEFA14A
Importance Score:
8
CING
Mar 18, 2026, 8:13 AM EDT
Filing Type: 10-K
Importance Score:
9
CING
Mar 18, 2026, 8:10 AM EDT
Filing Type: 8-K
Importance Score:
9